Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib
Authors:
- 19 November 2021
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 23 (1) , 1-7
Abstract
Cyclin‑dependent‑kinase 4‑6 inhibitors (CDK4/6i) have improved the management of hormone receptor (HR)+/human epidermal growth factor receptor (HER)2‑ metastatic breast cancer (mBC). Currently, there are no valid prognostic factors for response to CDK4/6i. Baseline lymphopenia is reported as a prognostic factor in several types of cancer. The present retrospective study aimed to evaluate the effect of baseline absolute lymphocyte count (ALC) on response to palbociclib. Progression‑free survival (PFS) was the primary endpoint. Secondary endpoints were overall survival (OS), best response and safety. A total of 114 patients treated for mBC between 2016 and 2019 were included. Median baseline ALC was 1.4 g/l (range, 0.2‑4.3 g/l). A total of 65 (57%) and 49 (43%) patients had baseline ALC values of +/HER2‑ mBC treated with palbociclib and endocrine therapy. Lymphopenia may also be a predictive factor of early progression. These data need to be verified in a larger prospective study.Keywords
This publication has 50 references indexed in Scilit:
- The Association Between Treatment-Related Lymphopenia and Survival in Newly Diagnosed Patients with Resected Adenocarcinoma of the PancreasCancer Investigation, 2012
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and TemozolomideClinical Cancer Research, 2011
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and LymphomasCancer Research, 2009
- Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical OutcomeCancer Research, 2009
- Thymopoiesis in elderly human is associated with systemic inflammatory statusAGE, 2009
- T cell immune reconstitution following lymphodepletionSeminars in Immunology, 2007
- Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late RelapseJournal of Clinical Oncology, 2006
- CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancerCancer, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- THE IMMUNOTHERAPY OF SOLID CANCERS BASED ON CLONING THE GENES ENCODING TUMOR-REJECTION ANTIGENSAnnual Review of Medicine, 1996